Capital Research Global Investors Purchases 88,544 Shares of Cencora, Inc. $COR

Capital Research Global Investors lifted its position in Cencora, Inc. (NYSE:COR) by 3.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,749,577 shares of the company’s stock after buying an additional 88,544 shares during the period. Capital Research Global Investors owned about 1.42% of Cencora worth $928,670,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in COR. Oakworth Capital Inc. bought a new position in shares of Cencora in the fourth quarter worth approximately $26,000. Elyxium Wealth LLC bought a new position in shares of Cencora in the fourth quarter worth approximately $27,000. Archer Investment Corp lifted its stake in shares of Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after buying an additional 47 shares in the last quarter. IAG Wealth Partners LLC bought a new position in shares of Cencora in the third quarter worth approximately $30,000. Finally, Caitlin John LLC bought a new position in Cencora during the third quarter valued at approximately $31,000. Institutional investors own 97.52% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on COR shares. Barclays increased their price objective on shares of Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. JPMorgan Chase & Co. increased their price objective on shares of Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Morgan Stanley set a $342.00 price objective on shares of Cencora in a research report on Friday, May 8th. Evercore set a $360.00 price objective on shares of Cencora in a research report on Wednesday, April 8th. Finally, Citigroup lowered their price objective on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Cencora currently has a consensus rating of “Moderate Buy” and a consensus target price of $380.25.

Cencora Stock Up 1.7%

Shares of COR stock opened at $274.94 on Friday. Cencora, Inc. has a 12 month low of $244.82 and a 12 month high of $377.54. The stock has a market cap of $53.49 billion, a P/E ratio of 21.08, a P/E/G ratio of 1.48 and a beta of 0.59. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The company has a 50 day simple moving average of $292.70 and a two-hundred day simple moving average of $330.55.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same period in the prior year, the company posted $4.42 earnings per share. The firm’s quarterly revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, research analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora announced that its Board of Directors has approved a share buyback plan on Thursday, May 21st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to purchase up to 3.9% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s management believes its shares are undervalued.

Cencora Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio is currently 18.40%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.